EVALUATION AND RANKING OF FACTORS AFFECTING THE ABILITY OF INNOVATION IN THE PHARMACEUTICAL INDUSTRY BY AHP
EVALUATION AND RANKING OF FACTORS AFFECTING THE ABILITY OF INNOVATION IN THE PHARMACEUTICAL INDUSTRY BY AHP
valeh foroutan1
1) Department of Technology Management, Faculty of Management, Tehran Science and Research Branch, Islamic Azad
IOI Code
:
XYCG-AEAAB
Publication :
international conference of Management Elites(icme.ir)
Abstract :
Innovation is now a key concept that is concerned by any organization – in any scale – in order to develop its own innovative culture and revise its organizational goals. It must be a necessity if a knowledge economy seeks the long-term sustainability. It is also fairly a proper guarantee for organizations to remain sustainable in the fast- promoting markets. In many countries today the drug industry is one of the strategic and knowledge-economy industries that benefits from high rates of innovation. Drug industry is one of strategic importance among iranian industries too. Due to the expanding markets and great investments in research and development fields of medicine, it is clear that drug companies have to increase the rate of innovation in their products. It is possible by promoting their dynamic capabilities, on the basis of understanding and responding fleeting chances in technology markets, in order to survive the competitive arena. Due to the importance of the issue, the present research focused on studying the state of the innovative capabilities in Tehran-Darou drug company, diagnosing the strong points, and determining the gap between the capability factors. The aim was to present some appropriate solutions to the problems of promotion of innovation in this company. It used the yam model with 8 dimensions and 63 factors. Gathering the data was done through questionnaires. The data was analyzed by Cronbach test and Alpha. The categorization of the research factors was done based on AHP hierarchical analytic model. In this way, the factors were ranked due to their weight. The findings show that Tehran-Darou drug company benefits a better state in the innovative-strategies dimension. It, however, needs some stronger improving solutions in the creative dimension.
Keywords : technology innovation innovation capability innovation system innovation management tehran daro company